Article
Irvine, CA-Allergan Inc. plans to launch its ketorolac tromethamine ophthalmic solution 0.4% (Acular LS) this summer for the reduction of ocular pain and burning and stinging following corneal refractive surgery.
ARVO announces Swathi Kaliki, MD, as recipient of 2025 Ludwig von Sallmann Clinician-Scientist Award
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Survey reveals gaps in patient awareness of preservative-free glaucoma treatments
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension
Tenpoint Therapeutics Ltd. appoints Carol Kearney as Chief Commercial Officer